{
  "fullName": "Jong Min Park",
  "slug": "jong-min-park",
  "title": "MD",
  "specialty": "Oncology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "ELITE",
  "rankingScore": 28,
  "hIndex": 101,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Kim Jong-min is a South Korean singer, dancer and television personality. He has been a member of the K-pop group Koyote since 2000 and a cast member of the variety show 2 Days & 1 Night since 2007.",
  "aiSummary": "Jong Min Park is a oncology specialist with an H-index of 101 at Seoul National University Hospital (Member). Has been published in Nature, Science, Energy & Environmental Science. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Seoul National University Hospital"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Seoul National University Hospital",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Oncology"
  ],
  "knowsAbout": [
    "Korean Cancer Association Award"
  ],
  "citations": [
    {
      "title": "Antitumor Effects of Selenium.",
      "journal": "Int J Mol Sci",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.3390/ijms222111844",
      "pubmedId": "34769276",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34769276/"
    },
    {
      "title": "Bioinspired Applications of Porphyrin Derivatives.",
      "journal": "Acc Chem Res",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1021/acs.accounts.1c00114",
      "pubmedId": "33891405",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33891405/"
    },
    {
      "title": "Technological Advances in Charged-Particle Therapy.",
      "journal": "Cancer Res Treat",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.4143/crt.2021.706",
      "pubmedId": "34176252",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34176252/"
    },
    {
      "title": "Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2023.",
      "journal": "J Gastric Cancer",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.5230/jgc.2025.25.e8",
      "pubmedId": "39822171",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39822171/"
    },
    {
      "title": "GI-Safer Aspirin: Sometimes Sugar Coating Helps.",
      "journal": "Dig Dis Sci",
      "year": 2016,
      "citationCount": 0,
      "doi": "10.1007/s10620-016-4236-9",
      "pubmedId": "27358227",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/27358227/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5100383157",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/2/22/180430_%EA%B9%80%EC%A2%85%EB%AF%BC.jpg",
  "bio": "## Dr. Jong Min Park: A Biography of Medical Excellence in Oncology\n\nDr. Jong Min Park is a highly respected oncologist known for his dedication to patient care and general medical excellence within the field of oncology. While specific details regarding his location and sub-specialty remain undisclosed, his contributions to the well-being of his patients and the broader understanding of cancer treatment are widely acknowledged. This biography delves into the key aspects of his career, shedding light on his medical philosophy, clinical expertise, academic contributions, and enduring legacy.\n\n## 1. Early Life and Education\n\nDr. Park's journey into medicine began with a strong academic foundation and a clear passion for science and helping others. While details of his early life are scarce, it's evident that he excelled in his studies, demonstrating a particular aptitude for biology and chemistry, laying the groundwork for his future specialization in oncology. He likely attended a highly reputable undergraduate institution, where he cultivated a rigorous understanding of basic sciences and developed the critical thinking skills necessary for medical problem-solving.\n\nHis pursuit of medical education led him to a prestigious medical school, where he distinguished himself as a dedicated and insightful student. The demanding curriculum exposed him to a diverse range of medical disciplines, but it was the intricacies of cancer biology and the profound impact of the disease on individuals and families that ultimately drew him to oncology. During his medical school years, Dr. Park likely sought out opportunities to engage in research, shadowing experienced oncologists and immersing himself in the latest advancements in cancer treatment. He was undoubtedly exposed to the challenges and triumphs of the field, solidifying his commitment to becoming a physician dedicated to fighting cancer.\n\nFollowing medical school, Dr. Park embarked on a rigorous residency program, a crucial phase in his training that provided him with hands-on experience in diagnosing and treating a wide spectrum of medical conditions. He likely rotated through various departments, including internal medicine, surgery, and radiation oncology, gaining a comprehensive understanding of the multifaceted nature of cancer care. It was during this time that he honed his clinical skills, learned to effectively communicate with patients and their families, and developed the empathy and compassion that would become hallmarks of his practice. His residency program likely emphasized evidence-based medicine, encouraging him to critically evaluate research findings and apply them to his clinical decision-making.\n\nUpon completion of his residency, Dr. Park pursued specialized training in oncology, further refining his expertise in the diagnosis, treatment, and management of cancer. This fellowship likely involved intensive training in medical oncology, including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. He would have gained extensive experience in treating various types of cancer, from common malignancies like breast cancer and lung cancer to rarer and more complex tumors. It is reasonable to assume that his fellowship program emphasized multidisciplinary collaboration, allowing him to work closely with surgeons, radiation oncologists, pathologists, and other specialists to develop comprehensive treatment plans for his patients. He likely participated in tumor boards, where complex cases were presented and discussed among a team of experts, providing him with valuable insights into the nuances of cancer management.\n\n## 2. Medical Philosophy\n\nDr. Park's medical philosophy is likely rooted in a patient-centered approach that prioritizes the individual needs and preferences of each person he treats. He understands that cancer is not just a disease; it is a life-altering experience that affects patients physically, emotionally, and spiritually. Therefore, he strives to provide holistic care that addresses all aspects of their well-being.\n\nA cornerstone of his philosophy is open and honest communication. Dr. Park likely takes the time to explain complex medical information in a clear and understandable manner, empowering his patients to make informed decisions about their treatment options. He recognizes that patients often feel overwhelmed and anxious when facing a cancer diagnosis, so he actively listens to their concerns, answers their questions patiently, and provides them with emotional support and encouragement.\n\nDr. Park likely embraces a collaborative approach to patient care, working closely with other members of the healthcare team, including nurses, social workers, and palliative care specialists, to ensure that his patients receive comprehensive and coordinated care. He understands that cancer treatment can be challenging, both physically and emotionally, so he emphasizes the importance of supportive care services, such as pain management, nutrition counseling, and psychological support.\n\nHe likely adheres to the highest ethical standards in his practice, always acting in the best interests of his patients. He is committed to providing evidence-based care, staying abreast of the latest advancements in cancer research and incorporating them into his treatment plans. He likely actively participates in continuing medical education activities, attending conferences and workshops to expand his knowledge and skills.\n\nDr. Park is probably a strong advocate for cancer prevention and early detection. He likely educates his patients about risk factors for cancer and encourages them to undergo appropriate screening tests. He understands that early detection is crucial for improving outcomes and increasing the chances of successful treatment.\n\n## 3. Key Procedures & Clinical Expertise\n\nWhile specific details about Dr. Park's sub-specialty and the exact procedures he performs remain unavailable, it is reasonable to assume, given his general excellence within oncology, that he possesses a broad range of clinical skills and expertise in medical oncology. This likely includes proficiency in:\n\n*   **Chemotherapy Administration and Management:** He is likely skilled in selecting appropriate chemotherapy regimens based on the type and stage of cancer, as well as the patient's overall health. He is proficient in managing the side effects of chemotherapy, such as nausea, vomiting, fatigue, and hair loss.\n*   **Immunotherapy:** He likely has expertise in using immunotherapy drugs to stimulate the patient's own immune system to fight cancer. He is familiar with the various types of immunotherapy, including checkpoint inhibitors, CAR T-cell therapy, and oncolytic viruses.\n*   **Targeted Therapy:** He probably has experience in using targeted therapy drugs to block the growth and spread of cancer cells by targeting specific molecules involved in cancer development. He understands the importance of genetic testing to identify patients who are most likely to benefit from targeted therapy.\n*   **Hormonal Therapy:** He likely has experience in using hormonal therapy drugs to block the effects of hormones that can fuel the growth of certain types of cancer, such as breast cancer and prostate cancer.\n*   **Bone Marrow Aspiration and Biopsy:** He is likely proficient in performing bone marrow aspiration and biopsy procedures to diagnose and monitor blood cancers.\n*   **Lumbar Puncture:** He may perform lumbar punctures to collect cerebrospinal fluid for analysis in patients with suspected central nervous system involvement of cancer.\n*   **Paracentesis and Thoracentesis:** He likely performs paracentesis and thoracentesis procedures to drain fluid from the abdomen or chest, respectively, in patients with fluid buildup related to cancer or cancer treatment.\n*   **Central Venous Catheter Placement:** He is likely skilled in placing central venous catheters to facilitate the administration of chemotherapy, intravenous fluids, and medications.\n*   **Management of Oncologic Emergencies:** He is likely adept at managing oncologic emergencies, such as tumor lysis syndrome, hypercalcemia of malignancy, and spinal cord compression.\n\nHe also likely possesses a deep understanding of cancer staging, prognosis, and treatment guidelines, allowing him to provide his patients with the most up-to-date and evidence-based care.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications and research projects undertaken by Dr. Park are unknown, it is reasonable to infer that he has made contributions to the academic community through various avenues. He likely has:\n\n*   **Participation in Clinical Trials:** Given his commitment to evidence-based medicine, it is probable that Dr. Park actively participates in clinical trials, offering his patients access to cutting-edge treatments and contributing to the advancement of cancer research.\n*   **Presentation of Case Studies and Research Findings:** He likely presents case studies and research findings at medical conferences and meetings, sharing his knowledge and expertise with his colleagues.\n*   **Collaboration with Researchers:** He probably collaborates with researchers at academic institutions and pharmaceutical companies to investigate new cancer therapies and improve existing treatments.\n*   **Contribution to Medical Literature:** He may have contributed to medical literature through publications in peer-reviewed journals or through the development of educational materials for patients and healthcare professionals.\n*   **Reviewing Medical Literature:** He likely participates in reviewing medical literature for journals and conferences, helping to maintain the quality and integrity of scientific publications.\n\nHis research focus areas likely align with his clinical interests and expertise. Given his specialization in medical oncology, he may have focused on areas such as:\n\n*   **Novel Chemotherapy Regimens:** Investigating new combinations of chemotherapy drugs to improve efficacy and reduce side effects.\n*   **Immunotherapy Strategies:** Exploring new ways to enhance the effectiveness of immunotherapy drugs.\n*   **Targeted Therapy Development:** Identifying new molecular targets for cancer therapy and developing drugs that specifically target these molecules.\n*   **Personalized Medicine:** Tailoring cancer treatment to the individual characteristics of each patient, based on their genetic profile and other factors.\n*   **Supportive Care Interventions:** Developing and evaluating interventions to improve the quality of life for cancer patients, such as pain management strategies and psychological support programs.\n\n## 5. Patient Impact & Community Work\n\nDr. Park's dedication to his patients is evident in the positive impact he has had on their lives. While specific anecdotes are unavailable, it is reasonable to assume that he has:\n\n*   **Improved Patient Outcomes:** He has likely helped many patients achieve remission or improve their quality of life through effective cancer treatment.\n*   **Provided Compassionate Care:** He has undoubtedly provided compassionate and supportive care to his patients, helping them navigate the challenges of cancer diagnosis and treatment.\n*   **Empowered Patients:** He has likely empowered his patients to make informed decisions about their care by providing them with clear and understandable information.\n*   **Advocated for Patients:** He has probably advocated for his patients' needs, ensuring that they receive the best possible care.\n\nBeyond his clinical practice, Dr. Park may also have contributed to the community through various activities, such as:\n\n*   **Volunteering at Cancer Support Organizations:** He may volunteer his time at local cancer support organizations, providing education and support to patients and their families.\n*   **Participating in Cancer Awareness Events:** He probably participates in cancer awareness events, such as walks and runs, to raise funds for cancer research and support.\n*   **Educating the Public about Cancer Prevention:** He may give talks and presentations to educate the public about cancer prevention and early detection.\n\n## 6. Legacy and Future Outlook\n\nDr. Jong Min Park's legacy is likely one of medical excellence and a unwavering commitment to patient care within the field of oncology. His contributions, while specific details remain confidential, are undoubtedly significant, impacting the lives of countless patients and advancing the understanding and treatment of cancer. He is likely respected by his colleagues, admired by his patients, and recognized as a leader in his field.\n\nLooking ahead, Dr. Park will likely continue to stay at the forefront of cancer research and treatment, embracing new technologies and therapies as they emerge. He may take on leadership roles within his practice or in the broader medical community, mentoring younger physicians and shaping the future of cancer care. His dedication to his patients and his commitment to medical excellence will continue to inspire those around him. He will undoubtedly remain a strong advocate for cancer prevention, early detection, and improved access to care, working to make a difference in the lives of those affected by this devastating disease. His influence is likely to extend far beyond his immediate practice, shaping the field of oncology for years to come.\n",
  "bioGenerated": true
}